Artenga
About Artenga
The company's goal is to develop medical devices to improve care for people with serious diseases. The current focus aims to provide medical researchers with an effective, flexible means to develop treatments and diagnosis through the use of microbubbles. Microbubbles are a proven medical product used to enhance ultrasound imaging. Researchers and physicians are beginning to demonstrate the enormous potential of ultrasound and microbubble enhanced therapies " please see resources for a list of publications. Artenga's medical device is annon-demand system to generate microbubbles optimized for therapy.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Artenga Patents
Artenga has filed 3 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/7/2010 | 3/25/2014 | Medical ultrasonography, Fluid dynamics, Medical equipment, Ultrasound, Acoustics | Grant |
Application Date | 1/7/2010 |
|---|---|
Grant Date | 3/25/2014 |
Title | |
Related Topics | Medical ultrasonography, Fluid dynamics, Medical equipment, Ultrasound, Acoustics |
Status | Grant |
Artenga Frequently Asked Questions (FAQ)
Who are Artenga's competitors?
Competitors of Artenga include Keystone Dental, HistoSonics, ADVOS, Aethlon Medical, Promedtek and 11 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare Artenga to Competitors
Emergent Respiratory Products, Inc., located in Irvine, CA, aims to develop, manufacture and market a medical device for delivering non-invasive ventilation therapy. Emergent's products can be utilized in a range of care settings, including emergency medical service (EMS) transport to the hospital and alternative site/home care settings.
Respiratory and infusion therapy for patients at home. Acquired by Lincare Holdings, Inc.
Aethlon Medical is the developer of the Hemopurifier - medical device that aims to treat infectious disease.
ADVOS is a combined multi-organ support system for liver, lung, kidney, and acid-base balance. Based on the principle of albumin dialysis, ADVOS allows both extracorporeal elimination of CO2, hepatic toxins, and water-soluble & protein-bound nephrotoxins, as well as the correction of metabolic and respiratory acidosis. The ADVOS procedure works with dialysis-usual access and flow rates and does not require a gas exchanger for CO2 elimination.
HistoSonics develops a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquefy unwanted tissue and tumors at sub-cellular levels. The company is focused on the development of its Edison platform, combining imaging with sensing technology to deliver personalized external beam treatments with precision and control, reducing the side effects of conventional therapies. The company was founded in 2009 and is based in Minneapolis, Minnesota.
Femeda is a UK based company focused on development of medical devices to treat incontinence and aims to offer solutions to conditions that can be accessed without visiting a healthcare professional.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
